Data / Drug companies / Doc Rx
Doc Rx: 15 products in the FDA NDC directory, labeler code 69306
Doc Rx (labeler code 69306) lists 15 products in the FDA National Drug Code Directory, covering 10 finished drugs by generic name. By type: 15 prescription drugs. Its main marketing category is generic drugs (ANDA). The newest product started marketing on July 31, 2025.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 69306
- Products in commercial distribution
- 15
- Packages
- 32
- Finished drugs by generic name
- 10
- Prescription products
- 15
- Over the counter products
- 0
- Started marketing in the last 12 months
- 0
- Earliest marketing start
- July 19, 1978
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 14 | 93.3% |
| Authorized generics (NDA) | 1 | 6.7% |
Products by type
| Type | Products | Share |
|---|---|---|
| Prescription drugs | 15 | 100% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Dexamethasone | 3 | 45 |
| Metaxalone | 2 | 38 |
| Methocarbamol | 2 | 67 |
| Cyclobenzaprine hydrochloride | 2 | 61 |
| Etodolac | 1 | 31 |
| Naproxen and esomeprazole magnesium | 1 | 10 |
| Ibuprofen and famotidine | 1 | 14 |
| Methylprednisolone | 1 | 31 |
| Azithromycin | 1 | 41 |
| Diclofenac potassium | 1 | 42 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 8 | 53.3% |
| Tablet, film coated | 5 | 33.3% |
| Tablet, delayed release | 1 | 6.7% |
| Capsule, extended release | 1 | 6.7% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
| Class | Products |
|---|---|
| Corticosteroid | 4 |
| Muscle Relaxant | 4 |
| Nonsteroidal Anti-inflammatory Drug | 4 |
| Proton Pump Inhibitor | 1 |
| Histamine-2 Receptor Antagonist | 1 |
| Macrolide Antimicrobial | 1 |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Cyclobenzaprine Hydrochloride | 69306-872 | Tablet, film coated | Generic drugs (ANDA) | July 31, 2025 |
| Methocarbamol | 69306-510 | Tablet | Generic drugs (ANDA) | May 22, 2025 |
| Diclofenac Potassium | 69306-750 | Tablet, film coated | Generic drugs (ANDA) | October 21, 2024 |
| Ibuprofen and famotidine | 69306-266 | Tablet, film coated | Generic drugs (ANDA) | August 4, 2021 |
| Methocarbamol | 69306-500 | Tablet | Generic drugs (ANDA) | January 1, 2021 |
| Naproxen and esomeprazole magnesium | 69306-005 | Tablet, delayed release | Generic drugs (ANDA) | February 18, 2020 |
| Metaxalone | 69306-100 | Tablet | Generic drugs (ANDA) | April 1, 2019 |
| Azithromycin | 69306-250 | Tablet, film coated | Generic drugs (ANDA) | March 12, 2019 |
| Cyclobenzaprine Hydrochloride | 69306-015 | Capsule, extended release | Authorized generics (NDA) | March 4, 2019 |
| Etodolac | 69306-020 | Tablet, film coated | Generic drugs (ANDA) | June 11, 2018 |
| Methylprednisolone | 69306-400 | Tablet | Generic drugs (ANDA) | May 14, 2018 |
| Metaxalone | 69306-311 | Tablet | Generic drugs (ANDA) | November 22, 2016 |
| Dexamethasone | 69306-111 | Tablet | Generic drugs (ANDA) | September 15, 1983 |
| Dexamethasone | 69306-112 | Tablet | Generic drugs (ANDA) | August 26, 1982 |
| Dexamethasone | 69306-114 | Tablet | Generic drugs (ANDA) | July 19, 1978 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.